From Positive News Media
Solon pushes for microbicides dev't
By
Aug 21, 2008 - 7:39:15 AM
MANILA, Aug. 21 (PNA) -- A lawmaker is pushing for a legislative measure that seeks for the development of a
new technology on microbicides to prevent transmission of sexually transmitted diseases (STDs), including the
human immunodeficiency virus (HIV).
Rep. Narciso D. Santiago III (Party-list, ARC), in filing House Bill 4744, said social, health and economic
burdens of STDs are especially severe for developing countries such as the Philippines, where the most affected
are women ages 15 to 49 years old.
STDs also represent the second largest cause of mortality and disability, Santiago said.
Under
the proposed measure, microbicides, like today's spermicides, would be
used vaginally by women to help protect themselves and their partners,
and protect unborn infants from the possible sexual transmission of HIV
and other STD pathogens.
Santiago
explained that these compounds could be formulated in a number of ways
such as a gel, film, sponge or time-released capsules.
"Microbicides,
once fully developed, could be used in addition to condoms or as an
alternative when condom use is not possible," he said.
Santiago
said the STDs that might be prevented from transmission in case
microbicides have already been developed are: chlamydia, gonorrhea,
syphilis, trichomoniasis, hepatitis B, herpes, human immunodeficiency
virus (HIV), and the human papilloma virus.
Among
these diseases, hepatitis B, herpes, HIV and the human papilloma virus
are incurable and these represent two-thirds (2/3) of the new
infections, he also said.
"These
diseases impose high human costs in pain, diminished quality of life,
disability and death and these infections also substantially enhance
susceptibility to HIV infection. This is what we want to lessen if not
totally stop," he added.
The
bill mandates the Department of Health (DOH) and all its components to
intensify studies and research on the initial mechanism of infection by
sexually transmitted pathogens.
It
also directs the DOH to develop appropriate animal models to evaluate
the safety and efficacy of microbicides, the development of a mucosal
delivery system, research on approaches to the design of contraceptive
and non-contraceptive microbicides, clinical trials, and
behavioral research on its use, acceptability and compliance of these
microbicides. (PNA)
© Copyright 2004 by Positive News Media